KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conagra Brands (CAG) Cash & Equivalents (2016 - 2025)

Conagra Brands (CAG) has 17 years of Cash & Equivalents data on record, last reported at $698.1 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents changed N/A year-over-year to $698.1 million; the TTM value through Aug 2025 reached $698.1 million, changed N/A, while the annual FY2025 figure was $68.0 million, 12.48% down from the prior year.
  • Cash & Equivalents reached $698.1 million in Q3 2025 per CAG's latest filing, up from $68.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $698.1 million in Q3 2025 and bottomed at $37.4 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $130.1 million, with a median of $78.5 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: tumbled 85.69% in 2021, then rose 12.0% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $68.7 million in 2021, then increased by 21.25% to $83.3 million in 2022, then increased by 12.0% to $93.3 million in 2023, then crashed by 59.91% to $37.4 million in 2024, then skyrocketed by 1766.58% to $698.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $698.1 million in Q3 2025, $68.0 million in Q2 2025, and $37.4 million in Q4 2024.